BIOLASE, Inc. provided earnings guidance for the fourth quarter and full year of 2023. The company currently expects full year 2023 revenue to be 1% to 3% higher than full year 2022 revenue. In addition, the Company expects net loss from operations for full year 2023 to be significantly improved compared to the comparable period for the prior year.

The Company expects net loss from operations for the fourth quarter of 2023 to be significantly improved compared to the comparable period for the prior year.